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Says Who? The significance of sampling in mental health surveys during COVID-19 
 
The COVID-19 pandemic is expected to have profound and enduring effects on mental health 
but, until we have data, we will not know its form, extent, duration, or distribution. An 
appropriate public health response to mitigate and manage mental health sequelae is likely to 
require significant diversion of resources. Such decisions must be underpinned by reliable 
information: policymakers, commissioners and services need to know both the scale of need 
and who is most vulnerable. A recent position paper in this journal1 highlights “an immediate 
priority is collecting high-quality data on the mental health effects of the COVID-19 
pandemic across the whole population and vulnerable groups”. This should be a clarion-call 
for governments to fund, and researchers to gather, timely, high-quality population mental 
health data which represents the true need arising from the pandemic.  
 
Instead, our desire for quick information has driven rapid propagation of online surveys using 
non-probability and convenience samples, some of which claim to be representative. 
Understandably, many are receiving widespread media attention. These early insights might 
be valuable, but we caution against relying on them to drive policy and resource because they 
are prone to substantial bias: acting on misleading information could be worse than having no 
information at all.  
 
Survey sampling and design choices must be led by their purpose. If the survey is to generate 
quick ideas, consult on perspectives, or foster community engagement, rapid, low-cost 
convenience sampling are appropriate. However, to understand prevalence in a population, 
how survey respondents are recruited is critically important. Non-probability samples are 
usually recruited by approaching membership lists; through service providers; existing large 
convenience panels; or from snowball recruitment using word-of-mouth, often via social 
media. Such samples attract volunteers who are already well-engaged, interested in the topic, 
and who do/can access the internet. Bias can affect any survey, but can be particularly 
problematic for social/mental health surveys where those excluded are often most in need. 
Individuals with existing or severe mental illness are less likely to participate online2, while 
half of over 75’s and many with mental illness, (key COVID-19 at-risk groups), are not 
regular internet users; access to digital devices is also limited amongst the most vulnerable 
and deprived children. Most surveys will weight their sample to match their target population 
by certain characteristics; however, these adjustments miss crucial elements of bias and 
cannot account for groups not included at all, particularly if the response rate is unknowable. 
A common misconception is that larger samples solve these biases. One Chinese study of 
mental health responses to the pandemic gathered an impressive 52,730 respondents3; 
however, 65% were female, indicating a highly skewed sample in a population with 
significantly fewer women than men4. We recommend all surveys detail their sampling 
strategy and to publish comparative statistics with the population they are sampled from, so 
informed judgements can be made about representativeness. 
 
The value of a survey depends on its data utility. Non-probability sampling lacks a sound 
theoretical basis for statistical inference5, which means basic descriptive analyses and 
explorations of potential associations are appropriate but measures of uncertainty i.e. 
confidence intervals around estimates of prevalence are generally not valid. Moreover, our 
ability to compare the population’s mental health pre- and post-COVID is compromised if 
surveys do not use standardised measures which are reliable and stable over time and if pre-
pandemic baseline data from the same population are not available.  
 
The current crisis has compromised several established data sources: health registries that 
previously quantified mental illness prevalence6 are reporting a drop in patient contacts - in 
the UK during March 2020, significantly fewer people presented to A&E and primary care 
with mental illness (personal communications). National registries of mental illness and 
suicide will catch-up, but are a poor tool in the short-term. Many official surveys have 
suspended data-collection in response to social distancing guidelines or transferred to remote 
interviews affecting comparability with prior waves7 and creating new challenges, such as 
how to gather sensitive data on self-harm/suicidality or intimate partner violence8.  
 
We believe it is both possible and cost-effective to generate high-quality evidence of mental 
health need in the current crisis. We recommend using random sampling to reduce risk of 
bias, allow quantification of non-response, and permit valid statistical analysis. A major 
investigation into  online survey panels9 concluded that “Researchers should avoid 
nonprobability online panels when...[the] objective is to accurately estimate population 
values.” Determining prevalence of COVID-19 mental health effects should use rigorous 
methods that sample from the whole population to reduce erroneous conclusions and 
potentially damaging actions. This approach may be more expensive, but is essential to gain 
reliable insights into how we mitigate psychological risks during this and future pandemics. 
Cutting corners to provide quick, cheap answers will result in poorer quality evidence, poorer 
policy, and wasted resources in the longer term. We can and must do better. 
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